How did REVB's operating expenses trend in Q4 2024 compared to previous quarters?
5/9/2025 08:18am
Revelation Biosciences' operating expenses for Q4 2024 are not currently available. However, based on the available data for Q1, Q2, and Q3 of 2024, the operating expenses were $0. This indicates that the company's operating expenses were not significant during these periods, and the trend was likely flat or decreasing compared to previous quarters.